טרימתוקסין וטרינרי ישראל - עברית - Ministry of Health

טרימתוקסין וטרינרי

romat ltd - sulfadimethoxine; trimethoprim - תמיסה (פומי) - trimethoprim 40 mg/g; sulfadimethoxine 200 mg/g

אמפרוזיד וטרינרי ישראל - עברית - Ministry of Health

אמפרוזיד וטרינרי

romat ltd - amprolium hydrochloride 25 %w/w - solution (oral) - coccidiosis in broilers, turkeys and layers.

טרימתוקסין וטרינרי ישראל - עברית - Ministry of Health

טרימתוקסין וטרינרי

romat ltd - sulfadimethoxine 200 mg/g; trimethoprim 40 mg/g - solution (oral) - broilers and turkeys: treatment of respiratory and urogenital infections caused by micro-organisms gram-positive and gram-negative sensitive to sulfamides and trimethoprim.

טאף % 25 וטרינרי ישראל - עברית - Ministry of Health

טאף % 25 וטרינרי

romat ltd - thiamphenicol - תמיסה (פומי) - thiamphenicol 250 mg/ml - for the treatment of bacterial diseases of the respiratory and intestinal system, caused especially by gram-positive and gram-negative micro-organisms, mycoplasmas and clamydiae in broilers.

אמפרוזיד וטרינרי ישראל - עברית - Ministry of Health

אמפרוזיד וטרינרי

romat ltd - amprolium hydrochloride - תמיסה (פומי) - amprolium hydrochloride 25 %w/w

Blood bank and laboratory devices ישראל - עברית - Ministry of Health

blood bank and laboratory devices

דוידוף א.א מסחר בינלאומי - אחות

סלאזופירין אי.אנ. ישראל - עברית - Ministry of Health

סלאזופירין אי.אנ.

pfizer pfe pharmaceuticals israel ltd - sulfasalazine - טבליות עם ציפוי אנטרי - sulfasalazine 500 mg - sulfasalazine - sulfasalazine - for active rheumatoid arthritis which is not controlled by antiinflammatory drugs. ulcerative colitis, crohn's disease, pyoderma gangrenosum.

סלאזופירין ישראל - עברית - Ministry of Health

סלאזופירין

pfizer pfe pharmaceuticals israel ltd - sulfasalazine - טבליה - sulfasalazine 500 mg - sulfasalazine - sulfasalazine - treatment of ulcerative colitis and crohn's disease.

קסניקל ישראל - עברית - Ministry of Health

קסניקל

tzamal bio-pharma ltd - orlistat - קפסולות - orlistat 120 mg - orlistat - orlistat - xenical is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (bmi) greater or equal to 30 kg/m2, or overweight patients (bmi > 28 kg/m2) with associated risk factors.

קומפטקט 15 מג  850 מג ישראל - עברית - Ministry of Health

קומפטקט 15 מג 850 מג

tzamal bio-pharma ltd - metformin hydrochloride; pioglitazone as hydrochloride - טבליות מצופות פילם - metformin hydrochloride 850 mg; pioglitazone as hydrochloride 15 mg - metformin - metformin - competact is indicated as second line treatment of type 2 diabetes mellitus adult patients,particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.after initiation of therapy with pioglitazone, patients should be reviewed after 3 to 6 months to assess adequacy of response to treatment (e.g. reduction in hba1c). in patients who fail to show an adequate response, pioglitazone should be discontinued. in light of potential risks with prolonged therapy, prescribers should confirm at subsequent routine reviews that the benefit of pioglitazone is maintained.